Br J Clin Pharmacol[object - Search Results

Year	Number of Results
1974	98
1975	111
1976	180
1977	235
1978	236
1979	416
1980	333
1981	288
1982	395
1983	397
1984	330
1985	322
1986	290
1987	276
1988	216
1989	301
1990	283
1991	275
1992	199
1993	213
1994	185
1995	224
1996	213
1997	207
1998	197
1999	236
2000	181
2001	199
2002	201
2003	206
2004	220
2005	206
2006	266
2007	291
2008	320
2009	214
2010	202
2011	232
2012	241
2013	274
2014	274
2015	324
2016	391
2017	357
2018	380
2019	354
2020	576
2021	37

1

COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?

Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C. Javelot H, et al. Br J Clin Pharmacol. 2020 Jun;86(6):1176-1177. doi: 10.1111/bcp.14335. Epub 2020 May 7. Br J Clin Pharmacol. 2020. PMID: 32350872 Free PMC article. No abstract available.

2

Chimeric antigen receptor T-cell therapy toxicities.

Greenbaum U, Kebriaei P, Srour SA, Olson A, Bashir Q, Neelapu SS, Rezvani K, Shpall EJ. Greenbaum U, et al. Br J Clin Pharmacol. 2020 May 28. doi: 10.1111/bcp.14403. Online ahead of print. Br J Clin Pharmacol. 2020. PMID: 32463929 Review.

3

Warfarin and food, herbal or dietary supplement interactions: A systematic review.

Tan CSS, Lee SWH. Tan CSS, et al. Br J Clin Pharmacol. 2020 Jun 1. doi: 10.1111/bcp.14404. Online ahead of print. Br J Clin Pharmacol. 2020. PMID: 32478963 Review.

4

Beyond dexamethasone, emerging immuno-thrombotic therapies for COVID-19.

Jensen MP, George M, Gilroy D, Sofat R. Jensen MP, et al. Br J Clin Pharmacol. 2020 Sep 2. doi: 10.1111/bcp.14540. Online ahead of print. Br J Clin Pharmacol. 2020. PMID: 32881064 Review.

5

The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence.

Chan AHY, Horne R, Hankins M, Chisari C. Chan AHY, et al. Br J Clin Pharmacol. 2020 Jul;86(7):1281-1288. doi: 10.1111/bcp.14193. Epub 2020 May 18. Br J Clin Pharmacol. 2020. PMID: 31823381 Free PMC article.

6

Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19.

Peña-Silva R, Duffull SB, Steer AC, Jaramillo-Rincon SX, Gwee A, Zhu X. Peña-Silva R, et al. Br J Clin Pharmacol. 2020 Jul 17:10.1111/bcp.14476. doi: 10.1111/bcp.14476. Online ahead of print. Br J Clin Pharmacol. 2020. PMID: 32779815 Free PMC article. No abstract available.

7

Effect of low-dose aspirin on health outcomes: An umbrella review of systematic reviews and meta-analyses.

Veronese N, Demurtas J, Thompson T, Solmi M, Pesolillo G, Celotto S, Barnini T, Stubbs B, Maggi S, Pilotto A, Onder G, Theodoratou E, Vaona A, Firth J, Smith L, Koyanagi A, Ioannidis JPA, Tzoulaki I. Veronese N, et al. Br J Clin Pharmacol. 2020 Aug;86(8):1465-1475. doi: 10.1111/bcp.14310. Epub 2020 Jun 2. Br J Clin Pharmacol. 2020. PMID: 32488906 Review.

8

Potential role of IL-17 blocking agents in the treatment of severe COVID-19?

Bulat V, Situm M, Azdajic MD, Likic R. Bulat V, et al. Br J Clin Pharmacol. 2020 Jul 5:10.1111/bcp.14437. doi: 10.1111/bcp.14437. Online ahead of print. Br J Clin Pharmacol. 2020. PMID: 32627226 Free PMC article. No abstract available.

9

Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy.

Mangan BL, McAlister RK, Balko JM, Johnson DB, Moslehi JJ, Gibson A, Phillips EJ. Mangan BL, et al. Br J Clin Pharmacol. 2020 Sep;86(9):1778-1789. doi: 10.1111/bcp.14433. Epub 2020 Jul 17. Br J Clin Pharmacol. 2020. PMID: 32543711 Review.

10

Goodbye to all that.

Cohen A. Cohen A. Br J Clin Pharmacol. 2019 Dec;85(12):2645-2648. doi: 10.1111/bcp.14124. Epub 2019 Dec 12. Br J Clin Pharmacol. 2019. PMID: 31828831 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results